References and Recommended Reading
Moersch FP, Woltman HW:Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome): report of a case and some observations in 13 other cases.Mayo Clin Proc 1956, 31:421–427.
Lorish TR, Thorsteinsson G, Howard FM:Stiff-man syndrome updated.Mayo Clin Proc 1989, 14:629–636.
Solimena M, Folli F, Denis-Donini S, et al.:Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.N Engl J Med 1988, 318:1012–1020.
Barker RA, Revesz T, Thom M, et al.:Review of 23 patients affected by the stiff person syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity.J Neurol Neurosurg Psychiatry 1998, 65:633–640.
Dalakas MC, Li M, Fujii M, Jacobowitz DM:Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD 65 antibodies.Neurology 2001, 57:780–784.
Of major importance Espay A, Chen R:Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome.Muscle Nerve 2006, 34:677–690. Excellent review that covers diagnosis, pathophysiology, and management of SPS.
Dalakas MC, Fujii M, McElroy B:The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.Neurology 2000, 55:1531–1535.
Solimena M, Folli F, Aparisi R, et al.Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.N Engl J Med 1990, 322:1555–1560.
Dalakas MC, Fujii M, Li M, et al.:High-dose intravenous immune globulin for stiff-person syndrome.N Engl J Med 2001, 345:1870–1876.
Raju R, Rakocevic G, Chen Z, et al.:Autoimmunity to GABAA-receptor-associated protein in stiff person syndrome.Brain 2006, 129:3270–3276.
Howard FM:A new and effective drug in the treatment of stiff-man syndrome: preliminary report.Mayo Clin Proc 1963, 38:203–212.
Helfgott SM:Stiff man syndrome: from the bedside to the bench.Arthritis Rheum 1999, 42:1312–1320.
Whelan J:Baclofen in the treatment of “stiff-man” syndrome.Arch Neurol 1980, 37:600–601.
Murinson BB, Rizzo M:Improvement of stiff-person syndrome with tiagabine.Neurology 2001, 57:366.
Ruegg SJ, Steck AJ, Fuhr P:Levetiracetam improves paroxysmal spasms in a patient with stiff-person syndrome.Neurology 2004, 62:338.
Spehlmann R, Norcross K, Rasmus SC, Schlageter NL:Improvement of stiff-man syndrome with sodium valproate.Neurology 1981, 31:1162–1163.
Meinck HM, Ricker K, Conrad B:The stiff-man syndrome: new pathophysiological aspects from abnormal exterocepative reflexes and the response to clomipramine, clonidine, and tizanidine.J Neurol Neurosurg Psychiatry 1984, 47:280–287.
Vicari AM, Folli F, Pozza G, et al.:Plasmapheresis in the treatment of stiff-man syndrome.N Engl J Med 1989, 320:1499.
Brashear HR, Phillips LH:Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome.Neurology 1991, 41:1588–1592.
Piccolo G, Cosi V, Zandrini C, Moglia A:Steroid-responsive and dependent stiff-man syndrome: a clinical and electrophysiological study of two cases.Ital J Neurol Sci 1988, 9:559–566.
McEvoy KM:Stiff-man syndrome. InNeurological Therapentics: Principles and Practice. Edited by Noseworthy J. London: Martin Dunitz; 2003:2400–2408.
Baker MR, Das M, Isaacs J, et al.:Treatment of stiff-person syndrome with rituximab.J Neurol Neurosurg Psychiatry 2005, 76:999–1001.
Iwata T, Inoue K, Mizuguchi S, et al.:Thymectomy for paraneoplastic stiff-person syndrome associated with invasive thymoma.J Thorac Cardiovasc Surg 2006, 132:196–197.
Hagiwara H:Stiff-person syndrome associated with invasive thymoma: a case report.J Neurol Sci 2001, 193:59–62.
Potter K:Physical therapy during in-patient rehabilitation for a patient with stiff-person syndrome.J Neurol Phys Ther 2006, 30:28–38.
Tinsley JA, Barth EM, Black JL, Williams DE:Psychiatric consultations in stiff-man syndrome.J Clin Psychiatry 1997, 58:444–449.
Westblom U:Stiff-man syndrome and clonazepam.JAMA 1977, 237:1930.
Knutsson E, Lindblom U, Martensson A:Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis.J Neurol Sci 1974, 23:473–484.
Penn RD, Mangieri EA:Stiff-man syndrome treated with intrathecal baclofen.Neurology 1993, 43:2412.
Stayer C, Tronnier V, Schwab S, Meinck HM:Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus.Neurology 1997, 49:1591–1597.
Silbert PL, Matsumoto JY, McManis PG, et al.:Intrathecal baclofen therapy in stiff-man syndrome: a double-blind placebo controlled trial.Neurology 1995, 45:1893–1897.
Bardutsky J, Tronnier V, Schwab S, Meinck HM:Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage.Neurology 2003, 60:1976–1978.
Meinck, HM, Tronnier V, Rieke K, et al.:Intrathecal baclofen treatment for stiff-man syndrome: pump failure may be fatal.Neurology 1994, 44:2209–2210.
Amato AA, Cornman EW, Kissel JT:Treatment of stiff-man syndrome with intravenous immunoglobulin.Neurology 2004, 44:1652–1654.
Souza-Lima CFL, Ferraz HB, Braz CA, et al.:Marked improvement in a stiff-limb patient treated with intravenous immunoglobulin.Mov Disord 2000, 15:358–359.
Harding AE, Thompson PD, Kocen RS, et al.:Plasma exchange and immunosuppression in the stiff man syndrome.Lancet 1989, 2:915.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lockman, J., Burns, T.M. Stiff-person syndrome. Curr Treat Options Neurol 9, 234–240 (2007). https://doi.org/10.1007/BF02938413
Issue Date:
DOI: https://doi.org/10.1007/BF02938413